Explain the reason why Tongrentang is famous at home and abroad with the historical facts of the 1950s-Baidu

Beijing Tongrentang is a well-known time-honored brand in Chinese medicine industry, which was founded in the eighth year of Emperor Kangxi of Qing Dynasty (1669). In the long history of more than 300 years, Tongrentang people in past dynasties have adhered to the traditional old saying that "although processing is complicated, we will not dare to save artificial flavor, although it is expensive, we will not dare to reduce material resources", and established the self-discipline consciousness of "no one knows what to make up for", ensuring the longevity of Tongrentang's golden signboard. Since the first year of Yongzheng (172 1), Tongrentang has been officially dedicated to the royal pharmacy of the Qing Dynasty. After eight emperors, it lasted 188 years, which created the meticulous spirit of Tongrentang people in the pharmaceutical process. Its products are famous at home and abroad for their unique formula, excellent materials, exquisite technology and remarkable curative effect. Tongrentang brand enjoys a good reputation at home and abroad and has unique advantages. Tongrentang trademark has been registered in Madrid Convention countries and Paris Convention countries and protected by international organizations. At the same time, it has gone through the registration procedures in more than 50 countries and regions around the world, and registered the first mainland trademark in Taiwan Province Province. Tongrentang's famous trademarks and excellent brands have become the unique advantages of Tongrentang Group's continuous development. Business scope of the company: manufacturing and processing of Chinese patent medicine preparations and cosmetics, technical consultation and technical services, and breeding and planting of medicinal animals and plants; Manage Chinese patent medicines, western medicine preparations and biochemical drugs; Self-management and agency for the import and export of all kinds of goods and technologies, except those restricted or prohibited by the state. The company is a professional company that produces, processes and sells Chinese patent medicines, with an annual output of about 265,438+0 dosage forms and more than 400 kinds. The main products are Niuhuang Qingxin Pill, Angong Niuhuang Pill, Dahuoluo Pill and Guogong Liquor. In the early 1990s, Tongrentang Group borrowed hundreds of millions of yuan, owed tens of millions of yuan in interest to banks, and its asset-liability ratio exceeded 70%, so its production and operation were in a very embarrassing situation. In this case, how to turn losses into profits? How to make the century-old brand continue to survive and develop? Mei Qun introduced that 1997, with the approval of Tongrentang leaders, he seized the historical opportunity of share reform and listing, and set up Beijing Tongrentang Co., Ltd. by divesting some high-quality assets and raising 354 million yuan, realizing institutional innovation and fundamentally getting rid of the predicament. In 2000, Beijing Tongrentang Technology Development Co., Ltd. was established by making full use of its own advantages and further increasing capital operation. In June of the same year, it became the first company in China to use the same state-owned assets for secondary financing and listing overseas. For Tong Ren Tang, most of the outstanding assets entered the listed companies after listing, and the non-performing assets remained in the matrix, which brought a heavy burden to the matrix. On the basis of ensuring the virtuous circle of listed companies, Tongrentang Group Company further carried out reform measures, entrusted some of its enterprises to two listed companies for management, and used the management mechanism of listed companies to transform its enterprises. 12 group companies successively entered two listed companies. The success of entrusted management not only created extremely favorable conditions for the mother to get out of trouble, but also saved about 500 million yuan of stock assets. In the past, the burden of enterprises, through the transformation of mechanism, has become a new resource and new driving force for enterprise development. At the same time, Tongrentang intensified its internal restructuring. All enterprises of Tongrentang Group have been restructured into joint-stock companies or limited liability companies, and all of them have achieved profits through corporate restructuring. The success of institutional reform has opened up a broader space for the development of Tong Ren Tang.